NewGenIvf (NIVF) Other Operating Expenses (2024 - 2025)

NewGenIvf (NIVF) posted quarterly Other Operating Expenses of -$17.1 million for Q4 2025, down 431.94% year-over-year from $5.1 million in Q4 2024, and down 578.64% quarter-over-quarter from $3.6 million in Q3 2025.

NewGenIvf (NIVF) Other Operating Expenses (2024 - 2025) Analysis & Trends

NewGenIvf (NIVF) has reported Other Operating Expenses for 2 consecutive years, with -$17.1 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Other Operating Expenses fell 431.94% year-over-year to -$17.1 million; the TTM figure through Dec 2025 stood at -$16.7 million (down 567.26% YoY), while the FY2025 annual figure was -$332480.0, up 84.95% from the prior year.
  • Other Operating Expenses retreated to -$17.1 million in Q4 2025 per NIVF's latest filing, from $3.6 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $3.6 million in Q3 2025 and bottomed at -$17.1 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 88.19 Bn 90.61 Bn 15.19 Bn
2 Tenet Healthcare 21.59 Bn 21.56 Bn 4.45 Bn
3 Encompass Health 12.19 Bn 12.86 Bn 1.34 Bn
4 Davita 11.52 Bn 12.39 Bn 1.16 Bn
5 Ensign 10.59 Bn 10.27 Bn 306.24 Mn
6 Universal Health Services 8.79 Bn 8.72 Bn 3.29 Bn
7 Pacs 7.04 Bn 6.88 Bn 338.46 Mn
8 Chemed 6.96 Bn 6.92 Bn 221.47 Mn
9 Concentra Group Holdings Parent 4.52 Bn 4.38 Bn 192.10 Mn
10 NewGenIvf 9,048.24 -1.43 Mn 524,025.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -17.08 Mn
Sep 30, 2025 3.57 Mn
Dec 31, 2024 -3.21 Mn
Sep 30, 2024 704,611.00